메뉴 건너뛰기




Volumn 26, Issue 6, 2015, Pages 699-702

Use of apixaban after development of suspected rivaroxaban-induced hepatic steatosis; A case report

Author keywords

Anticoagulants; Apixaban; Drug induced liver injury; Drug related sideeffects and adverse reactions; Factor Xa inhibitors; Fatty liver; Rivaroxaban

Indexed keywords

ALANINE AMINOTRANSFERASE; APIXABAN; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; RIVAROXABAN; WARFARIN; PYRAZOLE DERIVATIVE; PYRIDONE DERIVATIVE;

EID: 84942615886     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0000000000000363     Document Type: Article
Times cited : (13)

References (16)
  • 1
    • 84941188644 scopus 로고    scopus 로고
    • Titusville, NJ: Janssen Pharmaceuticals, Inc.
    • Xarelto [package insert]. Titusville, NJ: Janssen Pharmaceuticals, Inc.; 2015.
    • (2015) Xarelto [Package Insert]
  • 2
    • 79951784125 scopus 로고    scopus 로고
    • Evaluations of drug-induced serious hepatotoxicity (eDISH): Application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery
    • Watkins PB, Desai M, Berkowitz SD, Peters G, Horsmans Y, Larrey D, et al. Evaluations of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery. Drug Saf 2011; 34:243-252.
    • (2011) Drug Saf , vol.34 , pp. 243-252
    • Watkins, P.B.1    Desai, M.2    Berkowitz, S.D.3    Peters, G.4    Horsmans, Y.5    Larrey, D.6
  • 3
    • 84896544335 scopus 로고    scopus 로고
    • Risk of drug-induced liver injury with the new oral anticoagulants: Systematic review and meta-analysis
    • Caldeira D, Barra M, Santos AT, de Abreu D, Pinto FJ, Ferreira J, et al. Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis. Heart 2014; 100:550-556.
    • (2014) Heart , vol.100 , pp. 550-556
    • Caldeira, D.1    Barra, M.2    Santos, A.T.3    De Abreu, D.4    Pinto, F.J.5    Ferreira, J.6
  • 4
    • 33744506277 scopus 로고    scopus 로고
    • Drug-induced liver injury: Hy's rule revisited
    • Bjornsson E. Drug-induced liver injury: Hy's rule revisited. Clin Pharmacol Ther 2006; 79:521-528.
    • (2006) Clin Pharmacol Ther , vol.79 , pp. 521-528
    • Bjornsson, E.1
  • 5
    • 84901824190 scopus 로고    scopus 로고
    • An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data
    • Cheetham TC, Lee J, Hunt CM, Niu F, Reisinger S, Murray R, et al. An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data. Pharmacoepidemiol Drug Saf 2014; 23:601-608.
    • (2014) Pharmacoepidemiol Drug Saf , vol.23 , pp. 601-608
    • Cheetham, T.C.1    Lee, J.2    Hunt, C.M.3    Niu, F.4    Reisinger, S.5    Murray, R.6
  • 7
    • 6444234849 scopus 로고    scopus 로고
    • There Is No Evidence for an Increase in Acute Coronary Syndromes after Short-Term Abrupt Discontinuation of Statins in Stable Cardiac Patients
    • McGowan MP. There Is No Evidence for an Increase in Acute Coronary Syndromes After Short-Term Abrupt Discontinuation of Statins in Stable Cardiac Patients. Circulation 2004; 110:2333-2335.
    • (2004) Circulation , vol.110 , pp. 2333-2335
    • McGowan, M.P.1
  • 8
    • 0027362542 scopus 로고
    • Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of International Consensus Meeting: Application to drug-induced liver injuries
    • Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of International Consensus Meeting: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46:1323-1330.
    • (1993) J Clin Epidemiol , vol.46 , pp. 1323-1330
    • Danan, G.1    Benichou, C.2
  • 9
    • 84907964271 scopus 로고    scopus 로고
    • Symptomatic hepatocellular liver injury with hyperbilirubinemia in two patients treated with rivaroxaban
    • Liakoni E, Ratz BravoAE, Terracciano L, HeimM, Krahenbuhl S.Symptomatic hepatocellular liver injury with hyperbilirubinemia in two patients treated with rivaroxaban. JAMA Intern Med 2014; 174:1683-1686.
    • (2014) JAMA Intern Med , vol.174 , pp. 1683-1686
    • Liakoni, E.1    Ratz Bravo, A.E.2    Terracciano, L.3    Heim, M.4    Krahenbuhl, S.5
  • 10
    • 84930384694 scopus 로고    scopus 로고
    • Severe drug-induced skin and liver injury from rivaroxaban
    • Epub ahead of print
    • Barrett P, Vuppalanchi R, Masuoka H, Chalamsani N. Severe drug-induced skin and liver injury from rivaroxaban. Dig Dis Sci 2015; Epub ahead of print; doi: 10.1007/s10620-014-3504-9.
    • (2015) Dig Dis Sci
    • Barrett, P.1    Vuppalanchi, R.2    Masuoka, H.3    Chalamsani, N.4
  • 11
    • 33646198164 scopus 로고    scopus 로고
    • Anticoagulants and transaminase elevations
    • Arora N, Goldhaber SZ. Anticoagulants and transaminase elevations. Circulation 2006; 113:e698-e702.
    • (2006) Circulation , vol.113 , pp. e698-e702
    • Arora, N.1    Goldhaber, S.Z.2
  • 12
    • 8844255607 scopus 로고    scopus 로고
    • Princeton, NJ: Bristol-Myers Squibb Company
    • Coumadin [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; 2011.
    • (2011) Coumadin [Package Insert]
  • 13
    • 84930923588 scopus 로고    scopus 로고
    • Princeton, NJ: Bristol-Myers Squibb Company
    • Eliquis [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; 2014.
    • (2014) Eliquis [Package Insert]
  • 14
    • 84942658256 scopus 로고    scopus 로고
    • U.S. National Library of Medicine. Accessed Jan
    • National Institute of Diabetes and Digestive and Kidney Diseases. 'Spironolactone' LiverTox. U.S. National Library of Medicine. Accessed Jan. 2015. http://livertox.nih.gov/Spironolactone.htm.
    • (2015) Spironolactone LiverTox
  • 16
    • 84877301336 scopus 로고    scopus 로고
    • European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with nonvalvular atrial fibrillation
    • Heiduchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with nonvalvular atrial fibrillation. Europace 2013; 15:625-651.
    • (2013) Europace , vol.15 , pp. 625-651
    • Heiduchel, H.1    Verhamme, P.2    Alings, M.3    Antz, M.4    Hacke, W.5    Oldgren, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.